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Abstract 
In mammalian cytochrome c oxidase (COX) three of the ten nuclear coded subunits (Via, Vlla, VIII) occur in tissue-specific soforms. 
The isoform distribution, however, varies in liver and heart of different species. Subunit VIII is different in liver and heart of bovine, dog, 
rat and chicken, but identical in human (liver-type) on one hand, and sheep, rabbit and rainbow trout (heart-type) on the other hand, as 
determined by N-terminal sequencing. Two moles of trinitrophenyl-ATP bind to monomeric COX from bovine heart and one to COX 
from bovine liver with dissociation equilibrium constant (K d) values of about 3/zM. One binding site at the heart enzyme is blocked by a 
monoclonal antibody to subunit VIa-H. ATP (and/or ADP) interact with COX at two or three high-affinity binding sites, as shown by 
titration of the spectral changes of COX. Isolated COX from bovine heart was reconstituted with variable intraliposomal ATP/ADP 
ratios. By measuring the RCR (respiratory control ratio) and RCRva I (related to the valinomycin-respiration), which is a direct measure of 
the H+/e--stoichiometry (Wilson and Prochaska, Arch. Biochem. Biophys. 282 (1990) 413-420), almost complete inhibition of the 
proton pump activity of COX by high intraliposomal ATP concentrations was found. The vectorial uptake of protons for the formation of 
water, however, appears to be unaffected by nucleotides. This regulatory mechanism is assumed to have physiological significance for 
thermogenesis in muscle at rest. COX of fibroblasts from patients uffering from Leigh's syndrome, which is associated with a decreased 
COX activity, are suggested to have an imcompletely assembled enzyme complex. This suggestion is further corroborated by the higher 
temperature-sensitivity of the enzyme when compared with COX from normal control fibroblasts. Defective regulation of COX via 
nuclear coded subunits is also proposed to cause mitochondrial diseases. 
Keywords: Cytochrome c oxidase; Nucleotide binding; Tissue-specific sozyme; Subunit composition; Proton pump; Leigh's syndrome 
1. Control of mitochondrial ATP synthesis 
The synthesis of ATP in mitochondria by oxidative 
phosphorylation i volves four energy transducing enzyme 
complexes, all representing membrane-bound proton 
pumps. The respiratory chain contains complex I (NADH- 
UQ-oxidoreductase), complex III (UQH2-cytochrome c- 
oxidoreductase) and complex IV (cytochrome c oxidase 
(COX)), which translocate protons from the matrix into the 
cytosol, while the ATP-synthase (complex V) uses the 
electrochemical proton gradient across the inner mitochon- 
drial membrane to synthesize ATP. Electron transport from 
NADH to oxygen along the respiratory chain is accompa- 
nied by the free energy change (AG °' ) of 69.5, 40.5 and 
110 kJ/mol,  respectively. The free energy change at corn- 
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plexes I and III together is thus the same as that of 
complex IV, which represents an almost irreversible step. 
As pointed out in textbooks, essentially irreversible reac- 
tions are potential control sites. The activity of COX is 
thus expected to be controlled by allosteric effectors, in 
addition to the control by the concentrations of the sub- 
strates ferrocytochrome c and oxygen, and the membrane 
potential. 
2. Structure of cytochrome c oxidase (COX) 
COX from mammalia is composed of three mitochon- 
drial coded and ten nuclear coded subunits, which partly 
occur in tissue-specific isoforms [1,2]. The tissue-specific 
distribution of subunit isoforms, however, varies in differ- 
ent species. Table 1 shows the distribution of the heart- 
(H) and liver-type (L) of subunits Via, VIIa and VIII in 
liver and heart of various species. In liver usually the 
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Table 1 
Distribution of isoforms of COX subunits Via, VIIa and VIII in different 
species 
Tissue Subunit Via Subunit VI Ia Subunit VIII 
Liver Heart Liver Heart Liver Heart 
Human L L + H L L + H L L 
Bovine L H L H L H 
Sheep L H L + H H H H 
Dog L H L H L H 
Rabbit L L + H L L + H H H 
Rat L L+H L L L H 
Chicken unknown L + H H L H 
Rainbow trout absent L H H H 
The data are partly taken from Refs. [3] and [4] and from Freund (R. 
Freund (1994) Dissertation, Fachbereich C emie der Philipps-Universitat, 
D-35032 Marburg, Germany). L, liver-type isoform; and H, heart-type 
isoform. 
liver-type of subunits Via and VIIa occurs. In the heart of 
some species both, the liver- and heart-type isoforms of 
subunits Via and/or  VIIa occur together. In human heart, 
and in particular in human skeletal muscle, the heart-type 
of subunits Via and VIIa predominate, but an increase of 
the heart-type/liver-type ratio was shown during the tran- 
sition from fetal to adult stage [5]. Of particular interest is 
the observation, that subunit VIII occurs in liver and heart 
of some species only in one isoform, which could be either 
the liver-type (human) or the heart-type (sheep, rabbit and 
rainbow trout [4]). This result was verified by N-terminal 
sequencing of the corresponding gel bands, except for dog 
and chicken, where the apparent molecular weights of 
stained bands on SDS-PAGE gels were taken to deduce 
the L- and H-type of subunit VIII. The N-terminal amino 
acid sequences of subunits VIII from liver and heart of 
various species are presented in Table 2. The sequences 
clearly identify the liver- or heart-type of subunit VIII. 
Recently we isolated COX from liver and heart of 
rainbow trout and identified a new pair of tissue-specific 
isoforms for subunit Vb [4]. The fish enzymes are appar- 
ently lacking subunits Via and VIIb. The lack of subunit 
Table 2 
N-terminal mino acid sequences of subunits VIII from liver and heart of 
various pecies 
Liver Heart 
Human I H S L P P E G K L [6] dto [7] 
Bovine IHSKPPREQL[8 I  ITAKPARTPT[8]  
Rat VHSKPPREQL[9]  ISSKPAKSPT[9]  
Sheep dto [N] I T A K P A K T P T IN] 
Rabbit dto [N] I S G K P A R T P T [N] 
COX of liver and heart of sheep and rabbit was isolated by standard 
procedures [10], separated by SDS-PAGE [11], electroblotted onto 
ProBlott polyvinylidene difluoride membranes (Applied Biosystems), and 
the bands corresponding to subunit VIII were excised and applied to a 
model 477A protein sequencer (Applied Biosystems). Numbers inbrack- 
ets are references, [N] indicates new sequences, dto indicates the same 
sequence asin the other tissue. 
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Fig. 1. Spectral changes ofTNP-ATP after titration of isolated COX from 
bovine heart. COX (2 /.tM), isolated by standard procedures [10], was 
titrated in tandem cuvettes with TNP-ATP in 10 mM K-Hepes (pH 7.4), 
0.05% dodecyl maltoside, as described previously [15]. The TNP-ATP 
difference spectra were recorded from 350-550 nm 3 min after each 
addition. Squares, COX from heart; circles, COX from liver. Closed 
symbols, direct itration of the enzymes with TNP-ATP; open symbols, 
titration after preincubation with the monoclonal ntibody to subunits 
VIc + VIa-H. 
Via in the exothermic fish is of particular interest, because 
subunit VIa-H, expressed in heart and skeletal muscle of 
endothermic mammalia, is shown below to bind specifi- 
cally nucleotides, and is suggested to participate in 
muscle-specific thermogenesis at rest. Interestingly subunit 
Via occurs also in yeast and has been suggested to interact 
with ATP [ 12]. 
3. Interaction of nucleotides with cytochrome c oxidase 
In previous tudies on the effects of intraliposomal ADP 
on the kinetics of reconstituted COX, we have applied a 
monoclonal antibody which cross-reacts with bovine COX 
subunits VIc and VIa-H (heart-type) [13]. The cross-reac- 
tivity was shown to be due to sequence homologies be- 
tween these subunits [14]. With COX from bovine liver the 
antibody reacts only with subunit VIc, not with subunit 
VIa-L (liver-type) [13]. This antibody was now used to 
measure the binding of TNP-ATP (2'(or 3')-O-(2,4,6-tri- 
nitrophenyt)-ATP) to COX from bovine heart and liver, by 
following the change of absorbance of TNP-ATP at 425 
nm. In a previous study two binding sites for TNP-ATP 
were identified at COX from bovine heart [15]. As shown 
in Fig. 1, the binding of TNP-ATP to COX from bovine 
heart and liver shows saturation at about 20 /zM, but the 
amount of bound TNP-ATP is about twice in heart as 
compared to liver COX. Preincubation of the enzymes 
with the monoclonal antibody reduced the binding of 
TNP-ATP to the heart enzyme by about 50%, down to the 
level of the liver enzyme, but did not change the binding to 
the liver enzyme. These data suggest he presence of one 
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binding site for TNP-ATP at COX from bovine liver and 
two binding sites at COX from bovine heart, from which 
one binding site is located at subunit VIa-H. 
In further studies the binding of ATP and/or ADP to 
COX from bovine heart and liver was investigated by 
measuring the spectral change of the gamma-band of 
COX. In Fig. 2 the changes of the difference spectra at 
increasing concentrations of nucleotides are shown, which 
have a maximum at 425 nm. With both enzymes aturation 
of the absorbance changes are observed at about 100 /~M 
nucleotide. The titration curves show high- and low-affin- 
ity phases. ADP or ATP, added after preincubation with 50 
/~M nucleotide, results in an additional spectral change 
with the heart but not with the liver enzyme, indicating 
different nucleotide binding sites, with preference for ei- 
ther one of the nucleotides, at the heart enzyme. Prelimi- 
nary data from Scatchard plots on the binding of [35S]ATP 
to the heart enzyme indicate the presence of one high 
affinity binding site (K d about 1 /zM) and two low-affin- 
ity binding sites (Ko about 20 /zM) for ATP at the heart 
enzyme. 
4. Effect of nucleotides on proton pumping 
By using the monoclonal antibody to subunits VIc + 
VIa-H intraliposomal ADP was shown to stimulate the 
uncoupled respiration of reconstituted COX from bovine 
heart, but not from bovine liver, via binding to subunit 
VIa-H [13], and to stimulate the respiratory control ratio of 
the reconstituted heart enzyme [16]. Wilson and Prochaska 
[17] described a new parameter, RCRv,LI (respiratory con- 
trol ratio: valinomycin + CCCP-respiration/valinomycin- 
respiration), which is directly related to the H+/e--stoi  - 
chiometry of reconstituted COX - -  in contrast to the 
usually measured RCR (val inomycin + CCCP- 
respiration/control-respiration). We have measured the 
oxygen uptake of reconstituted COX from bovine heart 
with and without valinomycin and valinomycin + CCCP at 
increasing concentrations of cytochrome c (Fig. 3). The 
respiration without uncoupler is saturated at low concentra- 
tions of cytochrome c, whereas the uncoupled respiration 
increases with increasing concentrations of cytochrome c
up to 50 /~M. The valinomycin-respiration shows a maxi- 
mum at about 7 p.M cytochrome c. 
In a second series of experiments we have reconstituted 
COX from bovine heart in the presence of 10 mM total 
nucleotides but at varying ATP/ADP ratios, resulting in 
proteoliposomes with defined intraliposomal (matrix) 
ATP/ADP ratios. As shown in Fig. 4, the presence of 5% 
or higher portions of ADP within the vesicles leads to 
stimulation of the uncoupled respiration by about 40% at 5 
p~M cytochrome c and by about 15% at 50 ~M cy- 
tochrome c. The RCR values of the proteoliposomes are 
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Fig. 2. Spectral changes of COX from bovine heart and liver after titration with ATP and/or ADP. Isolated COX from bovine heart and liver [10] was 
titrated in tandem cuvettes with the indicated nucleotide in l0 mM K-Hepes (pH 7.4), 0.05% dodecyl maltoside. Difference spectra of COX were recorded 
from 400-500 nm, 3 min after each addition. (A,B) COX from heart, and (C,D) COX from liver. Closed symbols, titration with ATP; open symbols, 
titration with ADP. In (B) and (D), in addition to the ATP titration, a second titration is shown, where the titration up to 50 /zM ATP was followed by 
titration with ADP. 
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Fig. 3. Respiratory rate of reconstituted COX at increasing concentrations 
of cytochrome c in the absence and presence of valinomycin or valino- 
mycin+CCCP. COX was isolated from bovine heart mitochondria s 
described [10]. In order to improve the respiratory control ratio the final 
enzyme was dialyzed against 50 mM K-P i (pH 7.2), 0.1% Triton X-100 
and the DEAE-Sephacel chromatography and ammonium sulfate fraction- 
ation were repeated. Reconstitution of COX was performed by the 
hydrophobic adsorption method [13], in 10 mM K-Hepes (pH 7.4), 40 
mM KCI, 1.5% sodium cholate. Respiration of proteoliposome prepara- 
tions was measured by the polarographic method [13] in 10 mM K-Hepes 
(pH 7.4), 40 mM KC1, 25 mM Tris-ascorbate, 0.1 to 50 /xM cytochrome 
c (Sigma, type VI from horse heart), 0.02 /zM reconstituted COX, (i) 
without additions (squares), (ii) after addition of 1 /.~g/ml valinomycin 
(circles), and (iii) after addition of 3 /xM CCCP (carbonylcyanide-m- 
chlorophenylhydrazone) (triangles). The rate of respiration is presented as 
1 
turnover number (TN= mol electrons (4  02) (mol heme aa 3) ~ s t). 
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Fig. 4. Increase of uncoupled respiration of reconstituted COX with 
decreasing intraliposomal ATP and increasing ADP concentrations. Re- 
constitution of COX was done as described in the legend to Fig. 3, in the 
presence of various concentrations of ATP and/or ADP, whereby the 
total (intraliposomal) nucleotide concentration was held constant at 10 
mM. The turnover was measured at 5 (triangles) and 50 /.~M cytochrome 
c (squares) in the presence of 1 /xg/ml valinomycin and 3 /.LM CCCP 
with proteoliposomes containing the indicated percentage of intraliposo- 
real ADP. 
diminished, if the ATP concentration i the vesicles ex- 
ceeds 95% of total nucleotides (Fig. 5). The RCR de- 
creases from 16 to about 8 at 50 /~M cytochrome c and 
from 8 to 3 at 5 /zM cytochrome c, if the vesicles contain 
only ATP. The RCRva ] is even more affected by intralipo- 
somal nucleotides, which decreases from 8 to 3 at 50 /zM 
cytochrome c and from 3 to 1 at 5 /zM cytochrome c
concentrations at 100% (10 mM) intraliposomal ATP. 
These results suggest that the proton pump activity of 
COX, represented by RCRva ~, is turned off by intraliposo- 
real (matrix) ATP, but that the vectorial uptake of protons 
for the formation of water remains unaffected by the 
intraliposomal ATP/ADP ratio, since the RCR is only 
partly decreased at 100% intraliposomal ATP. 
No stimulation of respiration by intraliposomal ADP 
was previously found with the reconstituted liver enzyme 
[13]. We therefore conclude that the described regulation 
of the proton pump by the ATP/ADP ratio is due to 
binding of ATP and/or ADP to the N-terminal matrix-ori- 
ented domain of subunit VIa-H, and thus occurs only in 
heart and skeletal muscle tissue. A scheme for regulation 
of the proton pump in muscle COX by nucleotides is 
presented in Fig. 6. The specific involvement in proton 
translocation has been shown by site-directed mutagenesis 
for the conserved amino acid Asp-135 in subunit I of 
Escherichia coli quinol oxidase [18] and Asp-132 in sub- 
unit I of Rhodobacter sphaeroides COX [19], which corre- 
sponds to Asp-91 in subunit I of COX from bovine [20]. 
The location of both, the evolutionary conserved aspartic 
acid in subunit I of COX and quinol oxidase, and of the 
nucleotide-binding 17 N-terminal amino acids of subunit 
VIa-H on the intracellular (bacteria) or corresponding ma- 
trix side (bovine [21]), suggest a direct interaction of 
bound nucleotides with the proton pore-controlling con- 
served aspartic acid in subunit I. The physiological func- 
tion of turning off the proton pump in muscle COX at high 
matrix ATP/ADP ratios could be to stimulate thermogen- 
esis in skeletal muscle at rest (e.g., during sleep). 
5. Regulation of cytochrome c oxidase by other effec- 
tors 
It was suggested that the large number of 10 nuclear 
coded subunits in mammalian COX, which are absent in 
the bacterial enzyme [3], have the function to regulate the 
activity via binding of allosteric effectors like substrates, 
cofactors, ions and hormones [22]. In a recent report we 
could demonstrate a direct interaction of diiodothyronines 
(3,3'-T 2 and 3,5-T 2) with isolated COX from bovine heart 
[23]. Maximal stimulation of activity (about 50%) was 
obtained with low concentrations (10 -8 to 10 -6  M)  of 
3,3'-T 2 at pH 6.4 and with 3,5-T 2 at pH 7.4. In contrast, 
3,5,3'-triiodothyronine showed no or little stimulation of 
activity. Binding of the hormones to COX lead to confor- 
mational changes, as shown by changes in the visible 
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Fig. 5. Dependence of the respiratory control ratios RCR (A) and RCRva l 
(B) of reconstituted COX on the intra]iposomal concentrations of ATP 
and ADP. The total intraliposomal nucleotide concentration was held 
constant at 10 mM. The data were obtained at 5 /~M (triangles) and 50 
/~M cytochrome c (squares) and the indicated percentage of intraliposo- 
ma] ADP. 
spectra of the oxidized enzyme. It is suggested that 'short- 
term' effects of thyroid hormones on mitochondrial respi- 
ration are at least partly due to allosteric interaction of 
diiodothyronines with the COX complex. 
6. Disassembly of cytochrome e oxidase in Leigh's 
syndrome 
Mitochondrial diseases are often associated with COX 
deficiency [24]. In many cases the COX deficiency is due 
to mutations or deletions of the mitochondrial DNA 
(mtDNA) [25], coding for COX subunits l-I I I .  In other 
cases, like the Leigh syndrome, a nuclear-encoded protein 
was implicated, affecting the structure or the stability of 
the COX holoenzyme complex [26]. So far, in no case the 
molecular basis for a mitochondrial disease, based on 
nuclear mutations, has been established. From the changed 
kinetics of COX in fibroblasts from patients with Leigh's 
syndrome, a defective assembly of the enzyme complex 
was suggested [27,28]. 
We have investigated the properties of COX in fibrob- 
lasts of patients with Leigh's syndrome using immuno- 
logical and kinetic methods [29]. ELISA titrations of mito- 
chondria with monoclonal antibodies revealed a slight 
decrease of subunit II, intermediate decrease of subunit IV, 
Cytosol 2 H20 02  
nH + 
v C 
I 
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t~ NMR W 
L 
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NH2 A S A A 
Matrix 4H + ADP IH + ATP 
Fig. 6. Scheme of proposed regulation of the proton pump in COX from muscle. The 13 mostly transmembraneous (except subunits Va, Vb and VIb) 
subunits of mammalian COX are drawn by boxes with indicated cytosolic or matrix locations of their C- and N-termini, if known [3]. Asp-91 of bovine 
subunit I, located in a 21 amino acid loop between transmembraneous helices 2 and 3 on the matrix side [20], corresponds toAsp-135 of E. coli [18] and 
Asp-132 of R. sphaeroides [19], which both were shown to be involved in proton pumping. It is proposed that the 17 matrix-oriented N-terminal amino 
acids of subunit VIa-H, which were shown to bind the nucleotides [13], are in close contact with the loop of subunit I and control proton translocation 
according to the ATP/ADP ratio in the matrix. Cytochrome c is indicated by a large encircled C. 
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Fig. 7. Decreased thermostability of COX in cell extracts of fibroblast 
from patients with Leigh's syndrome. Cell lines from control and patients 
with Leigh's syndrome were obtained from Dr. C. Marsac, Paris and Dr. 
M.T. Zabot, Lyon. They were obtained from skin biopsy after informed 
consent. Fibroblasts were cultured according to standard procedures in 
RPMI 1640 medium with Glutamax I (Gibco BRL) supplemented with 
10% fetal calf serum. Enzyme activities were determined in sonicated cell 
homogenates after pretreatment with digitonin as described [29]. COX 
activity was measured according to Cooperstein and Lazarow [31] in 
0.1% dodecyl maltoside and citrate synthase according to Srere [32]. Cell 
extracts were incubated at 43 ° C, followed by enzyme activity determina- 
tion at the indicated times. Citrate synthase activity (open squares) was 
the same for control and patient fibroblasts. COX activity of patient 1 
(asterisks) showed 18%, patient 2 (crosses) 44% of control cells, but was 
set 100% at t = 0 min. 
and strong decrease (to about 35% of control) of subunits 
Vab, VIac and VIIab of COX from patients. The biphasic 
change of activity of dodecyl maltoside-dissolved COX 
upon titration with anions (phosphate or guanidinium chlo- 
ride); i.e., stimulation at low and inhibition at high anion 
concentrations, i  lost with COX from patients. An imme- 
diate inhibition of activity was found instead [29]. In 
previous studies the biphasic change of activity upon 
titration of isolated COX from bovine heart with potassium 
chloride was converted into monophasic inhibition after 
selective removal of subunit VIb [30]. Therefore, the de- 
scribed results point to disassembly of the COX complex 
in patients with Leigh's syndrome. This conclusion is 
further demonstrated in the experiment shown in Fig. 7, 
indicating an increased temperature sensitivity of COX 
from patients with Leigh's syndrome. During incubation 
for 60 rain at 43°C the activity of COX from control 
fibrohlasts decreased to 50%, that of patient 1 (44% COX 
activity from control under standard conditions) to 20% 
and that of patient 2 (18% COX activity from control) to 
0% of original activity. 
The modulation of COX activity and proton pumping 
by nucleotides, as described above, is at least in part due to 
interaction with nuclear-coded subunits. Incomplete assem- 
bly of COX will therefore impair the regulatory properties 
of COX. Therefore mitochondrial diseases with partial 
COX deficiency could also be based on impaired regula- 
tory functions of incomplete assembled holoenzyme. 
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